Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 7/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | TDO2 | P48775 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.30 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
| ▸ | P4HB | P07237 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20655953 | 0.88 | LIPG (0.44) | LPLLIPGROCK1IDO1TDO2 | |
| SCHEMBL21510251 | 0.81 | LPL (0.40) | LPLLIPGROCK1IRAK4PRMT5 | |
| SCHEMBL17739624 | 0.81 | LIPG (0.50) | LPLLIPGP4HB | |
| SCHEMBL31261579 | 0.81 | LIPG (0.50) | LPLLIPGP4HB | |
| SCHEMBL13832925 | 0.80 | LIPG (0.44) | LPLLIPGROCK1IDO1TDO2 | |
| SCHEMBL17923618 | 0.80 | LIPG (0.41) | LPLLIPGROCK1PGRIRAK4 | |
| SCHEMBL13231490 | 0.79 | PGR (0.42) | PGRSLC6A2 | |
| SCHEMBL24894123 | 0.78 | IRAK4 (0.37) | LPLLIPGROCK1IRAK4PRMT5 | |
| SCHEMBL24894055 | 0.76 | IRAK4 (0.36) | LPLLIPGROCK1IDO1TDO2 | |
| SCHEMBL15019779 | 0.76 | LPL (0.38) | LPLLIPGROCK1IDO1TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10468606-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2019-11-05 | — | — | US | disclosed |
| US-20190019962-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2019-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190019962-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, OR10J3 | LPL 3161/4885LIPG 1293/4885ROCK1 2861/4885 |
| US-10468606-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | PIEZO1, OCIAD1, OR10J3 | LPL 3161/4885LIPG 1293/4885ROCK1 2861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.